TOP TIERMARKET NEWSWIRE
News & sentiment

Insight Molecular Di (IMDX) — News & AI sentiment

Insight Molecular Di (IMDX) news roundup. 1 story in the past week, 7 over 30 days. Average 30-day sentiment is 58.3/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
1
avg sentiment 50/100
30d stories
7
avg sentiment 58.3/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

IMDX news in the last 24 hours, 7 days, 30 days and 90 days

How much IMDX coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowIMDX storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days150/100IMDX headlines →
Last 30 days758.3/100IMDX headlines →
Last 90 days2556.5/100IMDX headlines →

Latest stories on IMDX

Tech, Media & Telecom Roundup: Market Talk
WSJ Markets50 · neutralgeneral
5d ago
Sep 2
Sep 2
Lucid Capital Markets initiates Insight Molecular stock with buy rating
Investing.com Analyst Ratings61 · neutralanalyst
Aug 24
Aug 24
Aug 17
Aug 17
Aug 11
Aug 11
Aug 11
Aug 10
Aug 10
Aug 10
Aug 10
Aug 10
Aug 9
Aug 4
Health Care Roundup: Market Talk
Yahoo Top50 · neutralgeneral
Jul 27
Jul 23
Jul 21
Jun 29
Jun 22
Jun 19
Jun 17
Jun 16
Open IMDX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →